naltrexone has been researched along with sk&f-38393 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, FI | 1 |
| Kameyama, T; Toyoshi, T; Ukai, M | 1 |
| Armstrong, WE; Crowley, WR; Grosvenor, CE; Parker, SL; Wang, W | 1 |
| Bodnar, RJ; Hobbs, DJ; Koch, JE | 1 |
| Bodnar, RJ; Koch, JE; Schaefer, LA | 1 |
| Moody, CA; Robinson, SR; Smotherman, WP; Spear, LP | 1 |
| Fanselow, MS; Zelikowsky, M | 1 |
1 review(s) available for naltrexone and sk&f-38393
| Article | Year |
|---|---|
2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.
Topics: Animals; Biogenic Monoamines; Biological Transport; Carrier Proteins; Cocaine; Fluorescent Dyes; Humans; Isoquinolines; Ligands; Morphinans; Narcotic Antagonists; Piperidines; Protein Binding; Radioisotopes; Receptors, Opioid; Structure-Activity Relationship; Substance-Related Disorders | 2003 |
6 other study(ies) available for naltrexone and sk&f-38393
| Article | Year |
|---|---|
Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Grooming; Indoles; Injections, Intraventricular; Male; Mice; Morphinans; Motor Activity; Naltrexone; Sulpiride | 1992 |
Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Antagonists; Electric Stimulation; Female; Lactation; Naltrexone; Oxytocin; Pituitary Gland; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasopressins | 1991 |
Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Eating; Ergolines; Food Deprivation; Haloperidol; Male; Naltrexone; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 2. 2-deoxy-D-glucose.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Deoxyglucose; Dopamine Agonists; Dopamine Antagonists; Eating; Ergolines; Haloperidol; Male; Naltrexone; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Effects of dopamine and kappa opioid receptors on fetal responsiveness to perioral stimuli.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzazepines; Brain; Dopamine; Dose-Response Relationship, Drug; Female; Fetal Movement; Naltrexone; Pregnancy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Opioid, kappa; Stereotyped Behavior; Sucking Behavior | 1993 |
Opioid regulation of Pavlovian overshadowing in fear conditioning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics, Opioid; Analysis of Variance; Animals; Behavior, Animal; Conditioning, Classical; Dopamine; Dopamine Agonists; Fear; Male; Models, Biological; Naltrexone; Narcotic Antagonists; Rats; Rats, Long-Evans | 2010 |